The KAPS-C Study: exploring knowledge and attitudes towards probiotic supplement use among people with cancer
Summary
We are conducting a survey on attitudes, awareness and use of probiotics in people previously or currently diagnosed with cancer. We are doing this in order to better understand probiotics' role in cancer care, to more effectively address the health needs of people with cancer. The findings will provide useful information to create better resources for patients and health care providers and help people make informed decisions about probiotic use in their treatment stategies.
Eligibility
Eligible ages: 18 to 100
Inclusion criteria:
In order to participate in this study, requirements include:
1) Current or previous diagnosis of cancer
2) Currently or previously underwent anti-cancer therapy (e.g. chemotherapy, surgery, radiation therapy, immunotherapy, etc.)
3) Aged 18 years or older
4) Live in Canada
5) Ability to read and write in English
Participate
Additional information
Contact information
For more information about this study, please contact Dr. Julie Deleemans (julie.deleemans@ucalgary.ca) or Muskaan Pamery (muskaan.pamery@ucalgary.ca).
Principal investigator:
Linda Ellen Carlson
Clinical trial:
No
REB-ID:
HREBA.CC-24-0410